Status:
COMPLETED
Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Botnar Research Centre for Child Health
Conditions:
COVID-19 Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study is to analyze the microglia reaction or direct neurotropic effects of CNS COVID-19 in pathogenesis and brain stem dysfunction in critically ill patients. A microglia-focused, brain-specific...
Detailed Description
This study is to analyze the microglia reaction or direct neurotropic effects of CNS COVID-19 in pathogenesis and brain stem dysfunction in critically ill patients. A microglia-focused, brain-specific...
Eligibility Criteria
Inclusion
- COVID-19 positive tested
Exclusion
- COVID-19 negative tested
- pregnant women
Key Trial Info
Start Date :
August 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 9 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04472013
Start Date
August 12 2020
End Date
November 9 2022
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurosurgery, University Hospital Basel
Basel, Switzerland, 4031